Literature DB >> 21868486

Prediction of long-term disability in multiple sclerosis.

R Schlaeger1, M D'Souza, C Schindler, L Grize, S Dellas, E W Radue, L Kappos, P Fuhr.   

Abstract

BACKGROUND: Little is known about the predictive value of neurophysiological measures for the long-term course of multiple sclerosis (MS).
OBJECTIVE: To prospectively investigate whether combined visual (VEP) and motor evoked potentials (MEP) allow prediction of disability over 14 years.
METHODS: A total of 30 patients with relapsing-remitting and secondary progressive MS were prospectively investigated with VEPs, MEPs and the Expanded Disability Status Scale (EDSS) at entry (T0) and after 6, 12 and 24 months, and with cranial MRI scans at entry (T2-weighted and gadolinium-enhanced T1-weighted images). EDSS was again assessed at year 14 (T4). The association between evoked potential (EP), magnetic resonance (MR) data and EDSS was measured using Spearman's rank correlation. Multivariable linear regression was performed to predict EDSS(T4) as a function of z-transformed EP-latencies(T0). The model was validated using a jack-knife procedure and the potential for improving it by inclusion of additional baseline variables was examined.
RESULTS: EDSS values(T4) correlated with the sum of z-transformed EP-latencies(T0) (rho = 0.68, p < 0.0001), but not with MR-parameters(T0). EDSS(T4) as predicted by the formula EDSS(T4) = 4.194 + 0.088 * z-score P100(T0) + 0.071 * z-score CMCT(UE, T0) correlated with the observed values (rho = 0.69, p < 0.0001).
CONCLUSION: Combined EPs allow prediction of long-term disability in small groups of patients with MS. This may have implications for the choice of monitoring methods in clinical trials and for daily practice decisions.

Entities:  

Mesh:

Year:  2011        PMID: 21868486     DOI: 10.1177/1352458511416836

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  14 in total

1.  Label-fusion-segmentation and deformation-based shape analysis of deep gray matter in multiple sclerosis: the impact of thalamic subnuclei on disability.

Authors:  Stefano Magon; M Mallar Chakravarty; Michael Amann; Katrin Weier; Yvonne Naegelin; Michaela Andelova; Ernst-Wilhelm Radue; Christoph Stippich; Jason P Lerch; Ludwig Kappos; Till Sprenger
Journal:  Hum Brain Mapp       Date:  2014-02-07       Impact factor: 5.038

2.  Effectiveness of multi-disciplinary rehabilitation for patients with Neuromyelitis Optica.

Authors:  Yael Nechemia; Elior Moreh; Harold Weingarden; Ayala Bloch; Uri Givon; Adi Vaknin-Dembinsky; Isabella Schwartz; Zeev Meiner; Gabi Zeilig
Journal:  J Spinal Cord Med       Date:  2016-03-24       Impact factor: 1.985

Review 3.  Personalized medicine in neurodegenerative diseases: how far away?

Authors:  Kristina Gotovac; Sanja Hajnšek; Marija Bošnjak Pašić; Nela Pivac; Fran Borovečki
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

4.  Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.

Authors:  Hanni S M Kiiski; Sinéad Ní Riada; Edmund C Lalor; Nuno R Gonçalves; Hugh Nolan; Robert Whelan; Róisín Lonergan; Siobhán Kelly; Marie Claire O'Brien; Katie Kinsella; Jessica Bramham; Teresa Burke; Seán Ó Donnchadha; Michael Hutchinson; Niall Tubridy; Richard B Reilly
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

5.  Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis.

Authors:  Xavier Giffroy; Nathalie Maes; Adelin Albert; Pierre Maquet; Jean-Michel Crielaard; Dominique Dive
Journal:  BMC Neurol       Date:  2016-06-01       Impact factor: 2.474

6.  Exploring the predictive value of the evoked potentials score in MS within an appropriate patient population: a hint for an early identification of benign MS?

Authors:  Nicolò Margaritella; Laura Mendozzi; Massimo Garegnani; Raffaello Nemni; Elena Colicino; Elisabetta Gilardi; Luigi Pugnetti
Journal:  BMC Neurol       Date:  2012-08-22       Impact factor: 2.474

Review 7.  Personalized medicine in multiple sclerosis: hope or reality?

Authors:  Tobias Derfuss
Journal:  BMC Med       Date:  2012-10-04       Impact factor: 8.775

8.  Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis.

Authors:  Silvia Rossi; Valeria Studer; Caterina Motta; Giorgio Germani; Giulia Macchiarulo; Fabio Buttari; Raffaele Mancino; Maura Castelli; Valentina De Chiara; Sagit Weiss; Gianvito Martino; Roberto Furlan; Diego Centonze
Journal:  J Neuroinflammation       Date:  2014-02-18       Impact factor: 8.322

9.  Improved characterization of visual evoked potentials in multiple sclerosis by topographic analysis.

Authors:  Martin Hardmeier; Florian Hatz; Yvonne Naegelin; Darren Hight; Christian Schindler; Ludwig Kappos; Margitta Seeck; Christoph M Michel; Peter Fuhr
Journal:  Brain Topogr       Date:  2013-10-02       Impact factor: 3.020

Review 10.  Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.

Authors:  Alberto Gajofatto; Massimiliano Calabrese; Maria Donata Benedetti; Salvatore Monaco
Journal:  Dis Markers       Date:  2013-11-10       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.